Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells.
Xi WangChengfu YuanBo HuangJiaming FanYixiao FengAlexander J LiBo ZhangYan LeiZhenyu YeLing ZhaoDaigui CaoLijuan YangDi WuXian ChenBin LiuWilliam WagstaffFang HeXiaoxing WuHuaxiu LuoJing ZhangMeng ZhangRex C HaydonHue H LuuMichael J LeeJennifer Moriatis WolfAilong HuangTong-Chuan HeZongyue ZengPublished in: ACS synthetic biology (2019)
As an important post-transcriptional regulatory machinery mediated by ∼21nt short-interfering double-stranded RNA (siRNA), RNA interference (RNAi) is a powerful tool to delineate gene functions and develop therapeutics. However, effective RNAi-mediated silencing requires multiple siRNAs for given genes, a time-consuming process to accomplish. Here, we developed a user-friendly system for single-vector-based multiplex siRNA expression by exploiting the unique feature of restriction endonuclease BstXI. Specifically, we engineered a BstXI-based shotgun cloning (BSG) system, which consists of three entry vectors with siRNA expression units (SiEUs) flanked with distinct BstXI sites, and a retroviral destination vector for shotgun SiEU assembly. For proof-of-principle studies, we constructed multiplex siRNA vectors silencing β-catenin and/or Smad4 and assessed their functionalities in mesenchymal stem cells (MSCs). Pooled siRNA cassettes were effectively inserted into respective entry vectors in one-step, and shotgun seamless assembly of pooled BstXI-digested SiEU fragments into a retroviral destination vector followed. We found these multiplex siRNAs effectively silenced β-catenin and/or Smad4, and inhibited Wnt3A- or BMP9-specific reporters and downstream target expression in MSCs. Furthermore, multiplex silencing of β-catenin and/or Smad4 diminished Wnt3A and/or BMP9-induced osteogenic differentiation. Collectively, the BSG system is a user-friendly technology for single-vector-based multiplex siRNA expression to study gene functions and develop experimental therapeutics.
Keyphrases
- mesenchymal stem cells
- poor prognosis
- epithelial mesenchymal transition
- high throughput
- cell proliferation
- cancer therapy
- umbilical cord
- binding protein
- real time pcr
- genome wide
- stem cells
- transforming growth factor
- long non coding rna
- bone marrow
- small molecule
- hyaluronic acid
- drug delivery
- dna methylation
- risk assessment
- cell therapy
- signaling pathway
- transcription factor
- oxidative stress
- high glucose
- low cost